How pharma companies can reduce the risk of failure with AI-based innovations.
Alan Marcus
Advertisement
Articles by Alan Marcus
Advertisement
Latest Updated Articles
Changing the Paradigm in AI ImplementationPublished: November 13th 2023 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
3
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
4
FDA Limits Regulations on Non-Medical Grade Wearable Fitness Devices
5